Table 2.
Antithrombotic therapy before and after left atrial appendage closure.
Pretreatment | Posttreatment, discharge | Posttreatment, 3 months | Posttreatment, 6/12 months | |
---|---|---|---|---|
n | 68 | 68 | 68 | 62 |
No antithrombotic therapy | 16 (23.5%) | 5 (7.3%) | 10 (14.7%) | 20 (32.3%) |
Single anti-platelet therapy | 12 (17.7%) | 29 (42.7%) | 40 (58.9%) | 34 (54.8%) |
Dual anti-platelet therapy | 23 (33.8%) | 32 (47.1%) | 16 (23.5%) | 8 (12.9%) |
Anticoagulant therapy | 17 (25.0%) | 2 (2.9%) | 2 (2.9%) | 0 (0.0%) |